Company Shares of TotalFinaElf S.A. (NYSE:TOT) Drops by -3.24%

TotalFinaElf S.A. (NYSE:TOT) : During the past 4 weeks, traders have been relatively bearish on TotalFinaElf S.A. (NYSE:TOT), hence the stock is down -1.67% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -4.47% relative to the S&P 500. The 4-week change in the price of the stock is -0.08% and the stock has fallen -3.24% in the past 1 week.

The company shares have dropped -3.68% from its 1 Year high price. On Oct 9, 2015, the shares registered one year high at $52.34 and the one year low was seen on Jan 20, 2016. The 50-Day Moving Average price is $47.62 and the 200 Day Moving Average price is recorded at $46.03.

The stock has recorded a 20-day Moving Average of 0.04% and the 50-Day Moving Average is 1.36%.


TotalFinaElf S.A. (NYSE:TOT): stock turned positive on Friday. Though the stock opened at $46.92, the bulls momentum made the stock top out at $47.2211 level for the day. The stock recorded a low of $46.71 and closed the trading day at $47.16, in the green by 1.90%. The total traded volume for the day was 1,182,518. The stock had closed at $46.28 in the previous days trading.

Total S.A. is an energy operator. The Company operates through three business segments: an Upstream segment, including alongside the activities of the exploration and production of hydrocarbons, the activities of gas and power; a Refining & Chemicals segment constituting an industrial hub comprising the activities of refining, petrochemicals and specialty chemicals and also includes the activities of oil trading and shipping; a Marketing & Services segment, including the global activities of supply and marketing in the field of petroleum products, as well as the activity of new energies, and a Corporate segment, which includes holdings operating and financial activities. Its projects include CLOV, EGINA, IKIKE, INCAHUASI, LAGGAN-TORMORE, OML-58 UPGRADE, EA-1 AND EA-1A (UGANDA), ELGIN – FRANKLIN REDEVELOPMENT and ABSHERON PH.1, among others.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *